[HTML][HTML] Early and late endocrine complications of COVID-19
P Kazakou, SA Paschou, T Psaltopoulou… - Endocrine …, 2021 - ec.bioscientifica.com
Endocrine system plays a vital role in controlling human homeostasis. Understanding the
possible effects of COVID-19 on endocrine glands is crucial to prevent and manage …
possible effects of COVID-19 on endocrine glands is crucial to prevent and manage …
[HTML][HTML] Differential co-expression network analysis reveals key hub-high traffic genes as potential therapeutic targets for COVID-19 pandemic
Background The recent emergence of COVID-19, rapid worldwide spread, and incomplete
knowledge of molecular mechanisms underlying SARS-CoV-2 infection have limited …
knowledge of molecular mechanisms underlying SARS-CoV-2 infection have limited …
[HTML][HTML] Glutathione supplementation as an adjunctive therapy in COVID-19
V Guloyan, B Oganesian, N Baghdasaryan, C Yeh… - Antioxidants, 2020 - mdpi.com
Morbidity and mortality of coronavirus disease 2019 (COVID-19) are due in large part to
severe cytokine storm and hypercoagulable state brought on by dysregulated host …
severe cytokine storm and hypercoagulable state brought on by dysregulated host …
[HTML][HTML] A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm
Evaluating the effect of convalescent plasma (CP) on some cytokine storm indices in severe
COVID-19 patients. Totally, 62 patients were randomly assigned into two groups for this …
COVID-19 patients. Totally, 62 patients were randomly assigned into two groups for this …
[HTML][HTML] Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview
Abstract In December 2019, Coronavirus Disease 2019 (COVID-19) was reported in Wuhan,
China. Comprehensive strategies for quick identification, prevention, control, and remedy of …
China. Comprehensive strategies for quick identification, prevention, control, and remedy of …
[HTML][HTML] Molecular rationale for SARS-CoV-2 spike circulating mutations able to escape bamlanivimab and etesevimab monoclonal antibodies
The purpose of this work is to provide an in silico molecular rationale of the role eventually
played by currently circulating mutations in the receptor binding domain of the SARS-CoV-2 …
played by currently circulating mutations in the receptor binding domain of the SARS-CoV-2 …
[HTML][HTML] The prevalence and impact of coinfection and superinfection on the severity and outcome of COVID-19 infection: an updated literature review
SA Omoush, JAM Alzyoud - Pathogens, 2022 - mdpi.com
Patients with viral illness are at higher risk of secondary infections—whether bacterial, viral,
or parasitic—that usually lead to a worse prognosis. In the setting of Corona Virus Disease …
or parasitic—that usually lead to a worse prognosis. In the setting of Corona Virus Disease …
Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation
RXZ Lu, BFL Lai, N Rafatian, D Gustafson… - Lab on a Chip, 2022 - pubs.rsc.org
Coronavirus disease 2019 (COVID-19) was primarily identified as a novel disease causing
acute respiratory syndrome. However, as the pandemic progressed various cases of …
acute respiratory syndrome. However, as the pandemic progressed various cases of …
[HTML][HTML] SARS-CoV-2 involvement in central nervous system tissue damage
MA Haidar, Z Shakkour, MA Reslan… - Neural Regeneration …, 2022 - journals.lww.com
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread
globally, it became evident that the SARS-CoV-2 virus infects multiple organs including the …
globally, it became evident that the SARS-CoV-2 virus infects multiple organs including the …
[HTML][HTML] An assessment on impact of COVID-19 infection in a gender specific manner
Abstract Coronavirus disease 2019 (COVID-19) is caused by novel coronavirus Severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first time reported in …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first time reported in …